BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6766295)

  • 1. Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new).
    Yu VL; Vickers RM; Zuravleff JJ
    Antimicrob Agents Chemother; 1980 Jan; 17(1):96-8. PubMed ID: 6766295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
    Lyon MD; Smith KR; Saag MS; Cloud GA; Cobbs CG
    Antimicrob Agents Chemother; 1986 Jul; 30(1):25-30. PubMed ID: 3092731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative susceptibilities of 40 strains of Pseudomonas aeruginosa to 10 antipseudomonal antimicrobial agents.
    Davidson S; Lipshitz M; Bogokowski B; Rubinstein E
    Isr J Med Sci; 1982 Aug; 18(8):859-62. PubMed ID: 6811501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa.
    Hoogkamp-Korstanje JA; Westerdaal NA
    Infection; 1982; 10 Suppl 3():S257-61. PubMed ID: 6818158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of calcium, magnesium, and zinc on ticarcillin and tobramycin alone and in combination against Pseudomonas aeruginosa.
    Zuravleff JJ; Yu VL; Yee RB; Zaphyr MK; Diven W; Taylor FB
    Antimicrob Agents Chemother; 1982 Nov; 22(5):839-43. PubMed ID: 6817707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antibacterial activities of new beta-lactam antibiotics against Pseudomonas aeruginosa.
    Fernandes CJ; Stevens DA; Ackerman VP
    Chemotherapy; 1985; 31(4):292-6. PubMed ID: 3928282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined in vitro effect of new betalactam antibiotics and aminoglycosides against Pseudomonas aeruginosa ].
    Thabaut A; Durosoir JL; Meyran M
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):549-54. PubMed ID: 6812006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
    Pfaller M; Bale M; Preston T; Howard W; Koontz F
    Diagn Microbiol Infect Dis; 1986 May; 5(1):17-23. PubMed ID: 3086026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy of azlocillin with aminoglycosides.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():33-8. PubMed ID: 6413482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of cefoperazone compared to other antipseudomonal drugs.
    Nicoletti P; Mazzei T; Lamanna S
    G Batteriol Virol Immunol; 1981; 74(1-6):3-7. PubMed ID: 6458526
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
    Mintz L; Drew WL
    Antimicrob Agents Chemother; 1981 Feb; 19(2):332-4. PubMed ID: 6289731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
    Chandrasekar PH; Schell RF; LeFrock JL; Rolston KV; Francisco M
    Chemotherapy; 1984; 30(3):165-9. PubMed ID: 6428812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
    Reimer LG; Mirrett S; Reller LB
    Antimicrob Agents Chemother; 1980 Mar; 17(3):412-6. PubMed ID: 6448577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
    Murray PR
    Antimicrob Agents Chemother; 1980 Mar; 17(3):474-6. PubMed ID: 6252830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
    Markowitz SM; Sibilla DJ
    Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of the inoculum concentration on the in vitro sensitivity of Pseudomonas aeruginosa].
    Zarakolu P; Cöplü N; Güvener E
    Mikrobiyol Bul; 1993 Jul; 27(3):211-5. PubMed ID: 8361409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
    Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC
    J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432
    [No Abstract]   [Full Text] [Related]  

  • 20. In-vitro activity of cefpirome compared with that of other agents.
    Raizes EG; Cantey JR
    J Antimicrob Chemother; 1988 Feb; 21(2):177-81. PubMed ID: 3129388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.